Wednesday 27 April 2022, 12:00-13:00 CET
Cancer is a major health, social and public policy challenge and successfully tackling it requires an understanding of all its determinants. Although commercial determinants are a relatively new field of study, there are emerging themes which are very
important for cancer policy and the cancer control continuum.
Commercial determinants are those private-sector activities that affect the health of populations, but this is often neglected due to commercial interests often trumping nobler health
goals.
So, what are the commercial determinants of cancer control policy? What are the challenges and opportunities for governing them along the cancer control continuum? Join us to find out!
Keynote:
Marilys Corbex,
World Health Organization, Regional Office for Europe
Monika Kosinska, World Health Organization, HQ
Speakers:
Gauden Galea, World Health Organization Representative Office in China
Stuart Hogarth, University
of Cambridge
Richard Sullivan, Kings College London
Moderators:
Matthias Wismar & Erica Richardson, European Observatory on Health Systems and Policies
We would like to recognise the contribution of those who led the related Eurohealth Special Issue, including:
Special Guest Editors:
- Tit Albreht, National Institute of Public Health of Slovenia and the Faculty of Medicine, University of Ljubljana, Slovenia
- Marilys Corbex, World Health Organization, Regional Office for Europe, Copenhagen, Denmark
- Monika Kosinska, World Health Organization, Geneva, Switzerland
- Jose M. Martin-Moreno, Medical School and INCLIVA, Clinical Hospital, University of Valencia, Spain
Eurohealth Editors:
- Sherry Merkur, European Observatory on Health Systems and Policies, London, UK
- Gemma A Williams, European Observatory on Health Systems and Policies, London, UK